Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
Clinical trial NCT04764942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04764942
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2026-05-06
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.